Page 1



Volume V || Issue I || May - June 2014

The Gateway to Health & Medical World

PainProblems Size of Prostate Could Indicate

Prof (Dr) Rajeev Sood

Opportunities in

Scan the QR Code to know more

Healthcare Management

News Update | Doctor Speak | Expert Views | Product Line | Interview | Healthcare Management


Why is Document Imaging Important? Document imaging is the conversion of paper documents into electronic images on your computer. Once on your desktop, these documents can be retrieved effortlessly in seconds. Thousands of organizations around the world use document imaging every day instead of paper filing systems.

The Business Benefits are Obvious:

Common Challenges of Users:

ƒ Reduce the Risk of Losing Important Business Information

ƒ Time wasted in searching for misplaced or wrongly filed documents

ƒ Save Storage Space, Eliminate Need for File Cabinets

ƒ Issues in managing huge volume of documents

ƒ Find and Manage Records Easily

ƒ Document safety during disasters/accidents

ƒ Increase Productivity and Improve Customer Satisfaction

ƒ Issues in flexibility of easy retrieval of documents, especially when on the go

Capture Pro Software

Scanmate i940 Scanner

i2400 Scanner

Capture Pro Software

ƒ Storage space constraint

i2900 Scanner

Capture Pro Software

New Integrated Flatbed

Please contact Kodak Alaris India Pvt. Ltd. Toll free No: 1800228989

i1420 Scanner

Capture Pro Software

i3000 Scanner

Capture Pro Software

i4000 Series Scanner

Capture Pro Software

Available at DGS&D contract rate

© 2014 Kodak Alaris India Pvt. Ltd.

The Kodak trademark and trade dress are used under license from Eastman Kodak Company.

Licensed Product

New Launch Foley Catheter


Manufacturing wide range of surgical blades and scalpels which made us India’s No.1 Skin Graft Blade and World’s 3rd Largest Variety of Surgical blade Manufacturing Company. We are exporting premium quality surgical blade and scalpels in 85 countries worldwide Now introducing complete Range of Foley catheter manufacturing in the world class clean Room and state of the art manufacturing facility

Manufacture By:

RIBBEL INTERNATIONAL LTD Our products are accredited by

20th Mile, Jatheri Road, P.O. RAI, Near Rai Industrial Area Sonepat Haryana 131029 Tel: +91 8053111016, 8053111011 Fax: +91 11-23264398 Email: •

Editor’s note

The global infection control market will grow at a steady pace of around 6% from $10.5 billion in 2012 to $14.0 billion by 2017.


he rise in tide of cleaning standards and mounting pressure for sterilized and disinfected medical devices in hospitals and clinics has triggered the growth of medical sterilization and disinfection market. The increase in hospital acquired infections or nosocomial infections have forced the medical authorities to take stringent regulatory actions to curb these infections with the use of sterilized and disinfected medical devices. Gamma and E-beam types of sterilization services are poised to have better growth over EtO in the near future due to their wider application with respect to sterilization of food, pharmaceutical, medical devices, life sciences, and cosmetic products. Along with sterilization, cleaning and sanitation are also important activities carried out in healthcare, food, and pharmaceutical industry. Hand disinfectant market is the fastest growing segment as hands are considered to be the primary cause of cross infection. The demand for sanitizing and preservative disinfectants in food industry is also increasing due to high risks associated with foodborne pathogens along with other bacterial and viral food related infections. Increased focus on hygiene and spread of infections are the driving forces for disinfectants in the all the sectors. The endoscope reprocessing market is anticipated to show healthy growth in the near future due to continued instrument development and increasing minimally invasive surgery procedures. Riding on these factors, along with increasing usage of single-use technology products such as medical non-wovens and face masks, the global disinfection market is expected to grow at a CAGR of more than 6.0% from 2012 to 2017.

magazine Volume - V Issue - I May- June 2014

Editor Chief Editor Editorial Advisor

National Head Business Development Manager Asst. Manager Corporate Communication

Cheif Correspondent Design and Layout Sales and Marketing Subscribtion & Cirrculation

Dr. Pradeep Bhardawaj GP Capt. (Dr.) Sanjeev Sood Dr. Sharad Lakhotia Afzal Kamal Sunder Mewadi Sonia Pandit

SA Rizvi, Dr. HN Sharma Mohd. Javed Ahmad Amjad Kamal, SY Ahmed Khan, Ranjit Shirsath Jagruti Diddi, Saba Khan All right Reserved by all everts are made to insure that the information published is correct ‘Medgate today’ holds no responsibility any unlikely errors that might occur.

Published by

Advance Media Group Circulation Office: 92/17 Zakir Nagar, Opp. New Friends Colony, Okhla New Delhi - 110 025 Tel: +91 - 11 - 26981342 Fax: +91 - 11 - 26982464 M: +91 - 9212366351 Email: Visit us:

Mumbai Office

7 - Ground Floor, Aradhna CHS Ltd. Bal Samant Marg, Bandra (W), Mumbai-400 050

Chennai Office

11, Krishnan, Koil Street 3rd Floor Rotary Lane Chennai - 600001

Printed by

Artxel, 76, DSIDC Shed, Okhla Industrial Area Phase - II, New Delhi - 110020

Dr. Pradeep Bhardawaj Editor -in-Chief

Dr. ma Kamal

Have an insightful reading. Your suggestions are most welcome! E-mail: Website: w w w . m e d g a t e t o d a y . c o m


Nov - Dec 2013

May - June 2014 Contents

Hitex Healthcare, Industry Expert...

Understanding & Treating Heart Failure


Commander Manoj Kumar (Retd)

Doctor Speak & Exper Views

CEO, Hitex Healthcare

Dr. Vishal Rastogi Sr. Consultant, Cardiology


Fortis Escort Heart Institute

Master of the Heart


Dr. Aparna Jaswal

Pediatricians a Caring Hand for Children


Dr. Rajiva Kumar Child Specialist Muzaffarpur Bihar

Sr. Cardiologist Fortis Escort Heart Institute

Pain size of Prostate Could Indicate... Prof (Dr) Rajeev Sood


Head of Dept. Urology RML Hospital

Brain Aneurysms what everyone needs... Clinical Fellow Dept. of Neurosurgery


Dr. Vanita Arora

Sr. Consultant Max Super Speciality Hospital

Opportunities in Healthcare Management


Dr. Sudheer Ambekar

Heart Attack is not Sudden Cardiac...

Prof. M. Habeeb Ghatala Dean for Non-medical Institutions, Apollo Health City


Ask a Question from Healthcare Industry...

Understanding & Treating Heart Failure

A Guide for Patients and Families

Dr. Pradeep Bhardwaj


CEO & Executive Director Six Sigma Healthcare Ltd.


6 Cautious optimism for new... 8 Injecting new design 17 New Central Scanning ... 18 WHO’s first global report 20 zest2014 22 Medgatetoday & MFI jointly... 24 Medical Fair India 2014... 25 Integrating Virtual Reality...

32 Nov - Dec 2013

26 GE Healthcare & CTSI... 28 XVI National Seminar... 7

NEWS Update

Exanatide an alternative to insulin for type 2 patients

for new breast cancer drug An experimental inhibitor of cyclin-dependent kinases (CDK) 4 and 6 halves time to disease progression in women with hormone receptor positive metastatic breast cancer, researchers say.

For type 2 diabetes patients not controlled with oral hypoglycaemic drugs, exanatide may be an alternative to starting insulin treatment, three year findings from the DURATION-3 trial suggest.

Their phase 2 trial involved 165 women with advanced ER positive, HER2 negative breast cancer randomised to either letrozole plus CDK4/6 inhibitor palbociclib or to letrozole only.

A weekly injection of the long- acting GLP-1 receptor agonist provided better HbA1c control and also avoided weight gain and hypoglycaemic episodes seen with glargine insulin, according

However the study authors pointed out as only 61 of the 165 patients had died so far, statistical significance should not have been expected at this point in the trial and that data were trending in the right direction.

to study published in the Lancet Diabetes and Endocrinology.However, exanatide was less well tolerated than insulin, the study showed.In the DURATION-3 trial, 456 patients - including some from Australian centres with type 2 diabetes not controlled with oral drugs such as metformin and sulfonylureas were randomised to either a once-weekly SC injection of exanatide or once daily insulin glargine. 8

Cautious optimism

w w w . m e d e g a t e t o d a y. c o m

Presented yesterday at the annual meeting of the American Association for Cancer Research, the results showed those on palbociclib had a median time to disease progression of 20.2 months compared with 10.2 months with letrozole only. Overall survival was better in the palbociclib arm at 37.5 months compared with 33.3 months, but the difference failed to reach statistical significance.

The drug was generally well tolerated although adverse events included neutropenia, leukopenia, fatigue and anaemia.

RF ablation effective in Barrett’s with low-grade dysplasia Radiofrequency ablation (RFA) is far more effective than endoscopic surveillance at cutting the risk of progression to cancer in Barrett’s oesophagus with low-grade dysplasia, Dutch researchers find.In pathologist-confirmed lowgrade dysplasia, RFA cut the absolute risk of progression to high-grade dysplasia or adenocarcinoma within three years by a quarter compared with endoscopic surveillance (1.5% vs 26.5%),Absolute risk of progression to adenocarcinoma only was cut by 7.4% (1.5% vs 8.8%), the Amsterdam-based authors found. Complete eradication of dysplasia occurred in 93% of patients undergoing RFA compared with 28% of those in the surveillance arm, they said.Treatment-related adverse events occurred in a fifth of patients in the ablation group but these were mostly mild.The most common was oesophageal stricture, which resolved with a median of one endoscopic dilation. May - June 2014

NEWS Updat e

w w w . m e d e g a t e t o d a y. c o m

May - June 2014


Medgate Today Magazine - May-June 2014  

This is a free sample of Medgate Today Magazine issue "May-June 2014" Download full version from: Apple App Store: